Annual EBITDA
-$30.90 M
+$459.80 K+1.47%
December 31, 2023
Summary
- As of February 10, 2025, DARE annual EBITDA is -$30.90 million, with the most recent change of +$459.80 thousand (+1.47%) on December 31, 2023.
- During the last 3 years, DARE annual EBITDA has fallen by -$3.54 million (-12.95%).
- DARE annual EBITDA is now -4800.33% below its all-time high of -$630.60 thousand, reached on December 31, 2016.
Performance
DARE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.67 M
+$2.67 M+36.39%
September 30, 2024
Summary
- As of February 10, 2025, DARE quarterly EBITDA is -$4.67 million, with the most recent change of +$2.67 million (+36.39%) on September 30, 2024.
- Over the past year, DARE quarterly EBITDA has increased by +$489.90 thousand (+9.49%).
- DARE quarterly EBITDA is now -1299.08% below its all-time high of $389.60 thousand, reached on June 30, 2022.
Performance
DARE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$23.19 M
+$3.72 M+13.81%
September 30, 2024
Summary
- As of February 10, 2025, DARE TTM EBITDA is -$23.19 million, with the most recent change of +$3.72 million (+13.81%) on September 30, 2024.
- Over the past year, DARE TTM EBITDA has increased by +$7.71 million (+24.96%).
- DARE TTM EBITDA is now -2468.83% below its all-time high of -$902.70 thousand, reached on June 30, 2017.
Performance
DARE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DARE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.5% | +9.5% | +25.0% |
| 3 y3 years | -12.9% | +44.2% | +26.0% |
| 5 y5 years | -164.3% | +44.2% | +26.0% |
DARE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.9% | -1299.1% | +71.2% | at high | +44.7% |
| 5 y | 5-year | -115.6% | +20.9% | -1299.1% | +71.2% | -61.8% | +44.7% |
| alltime | all time | -4800.3% | +20.9% | -1299.1% | +71.2% | -2468.8% | +46.0% |
Dare Bioscience EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.67 M(-36.4%) | -$23.19 M(-13.8%) |
| Jun 2024 | - | -$7.34 M(+22.2%) | -$26.90 M(-5.7%) |
| Mar 2024 | - | -$6.01 M(+16.5%) | -$28.54 M(-7.6%) |
| Dec 2023 | -$30.90 M(-1.5%) | -$5.16 M(-38.5%) | -$30.90 M(-26.4%) |
| Sep 2023 | - | -$8.39 M(-6.6%) | -$41.96 M(+3.1%) |
| Jun 2023 | - | -$8.98 M(+7.2%) | -$40.71 M(+29.9%) |
| Mar 2023 | - | -$8.37 M(-48.4%) | -$31.34 M(-0.1%) |
| Dec 2022 | -$31.36 M(-19.7%) | -$16.22 M(+127.3%) | -$31.36 M(+27.1%) |
| Sep 2022 | - | -$7.14 M(-1931.6%) | -$24.68 M(-18.3%) |
| Jun 2022 | - | $389.60 K(-104.6%) | -$30.20 M(-24.0%) |
| Mar 2022 | - | -$8.40 M(-12.0%) | -$39.75 M(+1.8%) |
| Dec 2021 | -$39.04 M(+42.7%) | -$9.54 M(-24.7%) | -$39.04 M(+2.9%) |
| Sep 2021 | - | -$12.66 M(+38.3%) | -$37.94 M(+15.5%) |
| Jun 2021 | - | -$9.16 M(+19.1%) | -$32.85 M(+6.6%) |
| Mar 2021 | - | -$7.69 M(-8.9%) | -$30.80 M(+12.6%) |
| Dec 2020 | -$27.36 M(+90.9%) | -$8.43 M(+11.4%) | -$27.36 M(+20.1%) |
| Sep 2020 | - | -$7.57 M(+6.4%) | -$22.78 M(+22.3%) |
| Jun 2020 | - | -$7.11 M(+67.7%) | -$18.63 M(+20.2%) |
| Mar 2020 | - | -$4.24 M(+10.1%) | -$15.49 M(+8.1%) |
| Dec 2019 | -$14.33 M(+22.6%) | -$3.85 M(+12.8%) | -$14.33 M(+6.7%) |
| Sep 2019 | - | -$3.42 M(-14.2%) | -$13.44 M(+6.3%) |
| Jun 2019 | - | -$3.98 M(+29.2%) | -$12.64 M(+2.9%) |
| Mar 2019 | - | -$3.08 M(+4.2%) | -$12.28 M(+5.1%) |
| Dec 2018 | -$11.69 M | -$2.96 M(+12.9%) | -$11.69 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$2.62 M(-27.7%) | -$10.38 M(+14.2%) |
| Jun 2018 | - | -$3.62 M(+45.6%) | -$9.10 M(+52.8%) |
| Mar 2018 | - | -$2.49 M(+51.1%) | -$5.95 M(+61.3%) |
| Dec 2017 | -$3.69 M(+485.1%) | -$1.65 M(+23.6%) | -$3.69 M(+65.4%) |
| Sep 2017 | - | -$1.33 M(+178.0%) | -$2.23 M(+147.0%) |
| Jun 2017 | - | -$479.60 K(+109.9%) | -$902.70 K(-91.5%) |
| Mar 2017 | - | -$228.50 K(+21.2%) | -$10.62 M(-54.2%) |
| Dec 2016 | -$630.60 K(-98.3%) | -$188.60 K(+3043.3%) | -$23.21 M(-29.6%) |
| Sep 2016 | - | -$6000.00(-99.9%) | -$32.98 M(-23.3%) |
| Jun 2016 | - | -$10.20 M(-20.5%) | -$42.97 M(+2.0%) |
| Mar 2016 | - | -$12.82 M(+28.7%) | -$42.12 M(+13.9%) |
| Dec 2015 | -$36.97 M(+67.0%) | -$9.96 M(-0.4%) | -$36.97 M(+7.8%) |
| Sep 2015 | - | -$10.00 M(+6.9%) | -$34.28 M(+15.7%) |
| Jun 2015 | - | -$9.35 M(+22.0%) | -$29.63 M(+8.2%) |
| Mar 2015 | - | -$7.67 M(+5.4%) | -$27.38 M(+23.7%) |
| Dec 2014 | -$22.13 M(+43.2%) | -$7.27 M(+36.2%) | -$22.13 M(+23.8%) |
| Sep 2014 | - | -$5.34 M(-24.9%) | -$17.88 M(+16.7%) |
| Jun 2014 | - | -$7.11 M(+194.1%) | -$15.32 M(+20.4%) |
| Mar 2014 | - | -$2.42 M(-19.9%) | -$12.73 M(-17.7%) |
| Dec 2013 | -$15.46 M(-27.0%) | -$3.02 M(+8.6%) | -$15.46 M(+24.2%) |
| Sep 2013 | - | -$2.78 M(-38.5%) | -$12.44 M(+28.7%) |
| Jun 2013 | - | -$4.52 M(-12.3%) | -$9.66 M(+87.7%) |
| Mar 2013 | - | -$5.15 M | -$5.15 M |
| Dec 2012 | -$21.19 M | - | - |
FAQ
- What is Dare Bioscience annual EBITDA?
- What is the all time high annual EBITDA for Dare Bioscience?
- What is Dare Bioscience annual EBITDA year-on-year change?
- What is Dare Bioscience quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dare Bioscience?
- What is Dare Bioscience quarterly EBITDA year-on-year change?
- What is Dare Bioscience TTM EBITDA?
- What is the all time high TTM EBITDA for Dare Bioscience?
- What is Dare Bioscience TTM EBITDA year-on-year change?
What is Dare Bioscience annual EBITDA?
The current annual EBITDA of DARE is -$30.90 M
What is the all time high annual EBITDA for Dare Bioscience?
Dare Bioscience all-time high annual EBITDA is -$630.60 K
What is Dare Bioscience annual EBITDA year-on-year change?
Over the past year, DARE annual EBITDA has changed by +$459.80 K (+1.47%)
What is Dare Bioscience quarterly EBITDA?
The current quarterly EBITDA of DARE is -$4.67 M
What is the all time high quarterly EBITDA for Dare Bioscience?
Dare Bioscience all-time high quarterly EBITDA is $389.60 K
What is Dare Bioscience quarterly EBITDA year-on-year change?
Over the past year, DARE quarterly EBITDA has changed by +$489.90 K (+9.49%)
What is Dare Bioscience TTM EBITDA?
The current TTM EBITDA of DARE is -$23.19 M
What is the all time high TTM EBITDA for Dare Bioscience?
Dare Bioscience all-time high TTM EBITDA is -$902.70 K
What is Dare Bioscience TTM EBITDA year-on-year change?
Over the past year, DARE TTM EBITDA has changed by +$7.71 M (+24.96%)